New Developments in Cardiovascular Drugs: Heart Failure—An Informal and Personal Viewpoint

Abstract

The issue is not whether these drugs give short-term hemodynamic benefit when added to pre-existing therapy, as already found in several studies. Rather, the real point is any long-term effect on mortality. There have been too many drugs that should have had longterm benefit and did not, such as milrinone, flosequinan, ibopamine, and vesnarinone. Bearing in… (More)
DOI: 10.1023/A:1007798613232

Topics

Cite this paper

@article{Opie1997NewDI, title={New Developments in Cardiovascular Drugs: Heart Failure—An Informal and Personal Viewpoint}, author={Lionel Henry Opie}, journal={Cardiovascular Drugs and Therapy}, year={1997}, volume={11}, pages={519-520} }